Author

M. Cervantes

Observed names: Cervantes M, Cervantes M., M Cervantes, M Cervantes García, M. CERVANTES, M. Cervantes García, Manel Cervantes, Manel Cervantes Garcia, Manuel Cervantes, Manuel Cervantes García

Observed institutions: Universitat Autònoma de Barcelona, Hospital Universitario La Paz, Amsterdam UMC Location University of Amsterdam, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Hospital Clínic de Barcelona, Corporació Sanitària Parc Taulí, Institute of Research and Innovation Parc Tauli, Universidad Europea de Madrid

ORCID: 0000-0002-5464-3314

Observed ORCID: 0000-0002-5464-3314

OpenAlex ID: A5101938828

Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain

2020 · Juan Berenguer, Juan Berenguer, et al. · Clinical Microbiology and Infection · 401

PDF

Role of Weight-Based Ribavirin Dosing and Extended Duration of Therapy in Chronic Hepatitis C in HIV-Infected Patients: The PRESCO Trial

2007 · Marina Núñez, Celia Miralles, et al. · AIDS Research and Human Retroviruses · 189

Qt prolongation and Torsades de Pointes in patients infected with human immunodeficiency virus and treated with methadone

2003 · Merce Gil, Montserrat Sala, et al. · The American Journal of Cardiology · 113

Epidemiological and clinical features, response to HAART, and survival in HIV-infected patients diagnosed at the age of 50 or more

2006 · MaMercedes Nogueras, Gemma Navarro, et al. · BMC Infectious Diseases · 111

PDF

Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study

2021 · Daniel K Nomah, Juliana Reyes-Urueña, et al. · The Lancet HIV · 106

PDF

Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study

2021 · Belén Gutiérrez-Gutiérrez, María Dolores del Toro, et al. · The Lancet Infectious Diseases · 95

PDF

Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study

2020 · Sergio Serrano-Villar, Javier Martínez-Sanz, et al. · The Lancet HIV · 62

Recurrent Stroke as a Manifestation of Primary Angiitis of the Central Nervous System in a Patient Infected With Human Immunodeficiency Virus

2002 · Carmen Nogueras, Montserrat Sala, et al. · Archives of Neurology · 60

Expanding HIV clinical monitoring: the role of CD4, CD8, and CD4/CD8 ratio in predicting non-AIDS events

2023 · Javier Martínez-Sanz, Jorge Díaz-Álvarez, et al. · EBioMedicine · 52

PDF

Long-Term Safety and Efficacy of Nevirapine-Based Approaches in HIV Type 1-Infected Patients

2006 · Anna Bonjoch, Roger Paredes, et al. · AIDS Research and Human Retroviruses · 43

Seroprevalence of Bartonellaspp. infection in HIV patients in Catalonia, Spain

2008 · Immaculada Pons, Isabel Sanfeliu, et al. · BMC Infectious Diseases · 42

PDF

Effectiveness and tolerability of dolutegravir/lamivudine for the treatment of HIV-1 infection in clinical practice

2023 · Inés Suárez-García, Belén Alejos, et al. · Journal of Antimicrobial Chemotherapy · 36

PDF

Strategies to reengage patients lost to follow up in HIV care in high income countries, a scoping review

2021 · Jorge Palacio-Vieira, Juliana Maria Reyes-Urueña, et al. · BMC Public Health · 35

PDF

Incidence of anaemia and impact on sustained virological response in HIV/HCV‐coinfected patients treated with pegylated interferon plus ribavirin

2007 · M. Núñez, A. Ocampo, et al. · Journal of Viral Hepatitis · 30

Corticosteroids and tocilizumab reduce in-hospital mortality in severe COVID-19 pneumonia: a retrospective study in a Spanish hospital

2021 · E. Van den Eynde, O. Gasch, et al. · Scandinavian Journal of Infectious Diseases · 29

CD4 and CD8 Lymphocyte Counts as Surrogate Early Markers for Progression in SARS-CoV-2 Pneumonia: A Prospective Study

2020 · Joan Calvet, Jordi Gratacós, et al. · Viruses · 28

PDF

Results of a Study of Prolonging Treatment with Pegylated Interferon-α2A plus Ribavirin in HIV/HCV-Coinfected Patients with No Early Virological Response

2006 · Daniel Fuster, Ramon Planas, et al. · Antiviral Therapy · 25

PDF

Gastric mucormycosis in a patient with acquired immunodeficiency syndrome

1993 · Enric Brullet, Xavier Andreu, et al. · Gastrointestinal Endoscopy · 25

Mortality and immunovirological outcomes in patients with advanced HIV disease on their first antiretroviral treatment: differential impact of antiretroviral regimens

2022 · Joaquin Burgos, Sergio Moreno-Fornés, et al. · Journal of Antimicrobial Chemotherapy · 22

Premature Treatment Discontinuation in HIV/HCV-Coinfected Patients Receiving Pegylated Interferon plus Weight-Based Ribavirin

2007 · Vincent Soriano, Celia Miralles, et al. · Antiviral Therapy · 21

PDF

Impact of tenofovir on SARS-CoV-2 infection and severe outcomes among people living with HIV: a propensity score-matched study

2022 · Daniel K Nomah, Juliana Reyes-Urueña, et al. · Journal of Antimicrobial Chemotherapy · 20

Comparison of effectiveness and discontinuation of interferon‐free therapy for hepatitis C in prison inmates and noninmates

2018 · A. Marco, M. Roget, et al. · Journal of Viral Hepatitis · 18

Baseline Factors associated with Haematological Toxicity that Leads to a Dosage Reduction of Pegylated Interferon-α2a and Ribavirin in HIV- and HCV-Coinfected Patients on HCV Antiviral Therapy

2005 · Daniel Fuster, Jaime A Huertas, et al. · Antiviral Therapy · 18

PDF

Torsade de Pointes Due to Methadone

2003 · Montserrat Sala, Ignasi Anguera, et al. · Annals of Internal Medicine · 17

Recurrent hydrochlorothiazide-induced pulmonary edema

1998 · A. Mas, R. Jordana, et al. · Intensive Care Medicine · 17

Works count: 65

Citation count: 1,766

H-index: 20

I10-index: 29